Dimensional Fund Advisors
EDIT icon

Dimensional Fund Advisors’s Editas Medicine EDIT Stock Holding History

Dimensional Fund Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-335,479
Closed -$688K – 3243
2025
Q4 		$688K Sell
335,479
-596,431
-64% -$1.72M ﹤0.01% 2921
2025
Q3 		$3.23M Sell
931,910
-472,808
-34% -$1.32M ﹤0.01% 2650
2025
Q2 		$3.09M Sell
1,404,718
-203,759
-13% -$333K ﹤0.01% 2645
2025
Q1 		$1.87M Sell
1,608,477
-551,035
-26% -$811K ﹤0.01% 2743
2024
Q4 		$2.74M Sell
2,159,512
-107,598
-5% -$274K ﹤0.01% 2710
2024
Q3 		$7.73M Sell
2,267,110
-77,944
-3% -$339K ﹤0.01% 2387
2024
Q2 		$11M Sell
2,345,054
-262,711
-10% -$1.48M ﹤0.01% 2221
2024
Q1 		$19.3M Buy
2,607,765
+215,369
+9% +$1.79M 0.01% 2002
2023
Q4 		$24.2M Buy
2,392,396
+690,366
+41% +$6.06M 0.01% 1889
2023
Q3 		$13.3M Sell
1,702,030
-65,199
-4% -$559K ﹤0.01% 2110
2023
Q2 		$14.5M Buy
1,767,229
+155,476
+10% +$1.35M ﹤0.01% 2085
2023
Q1 		$11.7M Sell
1,611,753
-38,257
-2% -$340K ﹤0.01% 2163
2022
Q4 		$14.6K Buy
1,650,010
+993,508
+151% +$10.9M ﹤0.01% 2012
2022
Q3 		$8.04M Sell
656,502
-38,556
-6% -$601K ﹤0.01% 2251
2022
Q2 		$8.22M Sell
695,058
-171,857
-20% -$2.3M ﹤0.01% 2274
2022
Q1 		$16.5M Sell
866,915
-21,459
-2% -$399K 0.01% 2070
2021
Q4 		$23.6M Buy
888,374
+178,608
+25% +$6.15M 0.01% 1898
2021
Q3 		$29.2M Buy
709,766
+80,735
+13% +$4.42M 0.01% 1793
2021
Q2 		$35.6M Buy
629,031
+360,003
+134% +$13.3M 0.01% 1705
2021
Q1 		$11.3M Buy
269,028
+158,510
+143% +$9.03M ﹤0.01% 2274
2020
Q4 		$7.75M Buy
110,518
+92,108
+500% +$3.78M ﹤0.01% 2371
2020
Q3 		$517K Buy
+18,410
New +$600K ﹤0.01% 3055

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors's EDIT Position: Q1 2026 in Review

Dimensional Fund Advisors sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 335,479 shares — an estimated $688K sold.

Dimensional Fund Advisors first reported a position in EDIT in Q3 2020 and held it in 22 quarters. The position peaked at $35.6M in Q2 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Dimensional Fund Advisors reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 335,479 Editas Medicine shares in Q1 2026, an estimated $688K.
  • Dimensional Fund Advisors first reported a position in Editas Medicine in Q3 2020 and held it in 22 quarters.
  • Dimensional Fund Advisors's Editas Medicine position peaked at $35.6M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.